Again, [177Lu]Lu-PSMA-I&T revealed significantly higher level of binding in the kidney compared with [177Lu]Lu-PSMA-617, resulting in a significantly lower in vitro tumor-to-kidney ratio (Fig. 5d). The gene discussed is FOLH1; the disease is neoplasm.